Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00495209 · ClinicalTrials.gov registry record

Pre-Surgical Qigong Therapy for Women With Breast Cancer

A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
7
Enrollment target
1
Study location

NCT00495209: Completed study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00495209 is a study of Breast Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 7 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00495209, a study of Breast Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
7 participants
Enrollment target
1
Study location

Study Summary

The use of complementary and alternative medicine (CAM) in the United States has increased dramatically in the past 10 years. Nowhere is this trend more apparent than when one examines CAM use by patients diagnosed with cancer. As with the general population, patients with cancer typically use CAM-based modalities alongside their conventional cancer treatments. Patients are often seeking a holistic approach to managing and preventing disease. Although most patients will combine alternative approaches with conventional medicine, some patients do in fact decline curative conventional treatments in favor of more non-toxic alternative approaches. One such approach that patients combine with conventional medicine or use in place of conventional medicine is qigong. Qigong is a bioenergy therapy with a long history of therapeutic use for many diseases, including cancer. Preliminary experiments and a review of the literature show that qigong might improve the outcome for cancer patients. However, none of this research has been confirmed in the peer-reviewed Western scientific literature. Although it is unlikely that EQT will result in significant decreases in tumor size, patients are using qigong either as a complementary approach, and sometimes even in place of conventional medicine, it is, therefore, important for us to determine whether there is any merit to this treatment modality. The goal of this pilot trial is to examine one form of medical qigong (external qi therapy (EQT)) to determine feasibility. In an exploratory nature we will also examine any changes in tumor size in women with breast cancer who are awaiting surgery.

Conditions Studied

Interventions

  • OTHER Qigong

Study Locations (1)

Texas

  • UT MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2006-07-26
Est. Completion 2018-03-07

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00495209

The ClinicalTrials.gov registry entry for NCT00495209 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Qigong is the first listed.

NCT00495209 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00495209 about?

NCT00495209 is a clinical study titled "Pre-Surgical Qigong Therapy for Women With Breast Cancer". The use of complementary and alternative medicine (CAM) in the United States has increased dramatically in the past 10 years. Nowhere is this trend more apparent than when one examines CAM use by patients diagnosed with cancer. As with the general population, patients with cancer typically use CAM-b...

What is the current status of trial NCT00495209?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2006-07-26. Estimated completion is 2018-03-07.

What conditions does trial NCT00495209 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00495209?

The interventions under investigation include: Qigong (OTHER).

Who is sponsoring clinical trial NCT00495209?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00495209 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.